X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14338) 14338
Publication (2064) 2064
Book Review (1618) 1618
Book Chapter (157) 157
Dissertation (53) 53
Conference Proceeding (47) 47
Government Document (15) 15
Data Set (5) 5
Newspaper Article (4) 4
Web Resource (4) 4
Book / eBook (2) 2
Paper (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11420) 11420
humans (9011) 9011
pten (6475) 6475
animals (5142) 5142
oncology (4385) 4385
pten phosphohydrolase - metabolism (3851) 3851
female (3798) 3798
pten phosphohydrolase - genetics (3796) 3796
cancer (3700) 3700
male (3421) 3421
mice (3334) 3334
expression (2835) 2835
signal transduction (2830) 2830
cell biology (2598) 2598
apoptosis (2581) 2581
mutation (2463) 2463
cell line, tumor (2426) 2426
pten protein (2386) 2386
phosphorylation (2217) 2217
biochemistry & molecular biology (2188) 2188
proto-oncogene proteins c-akt - metabolism (2150) 2150
proteins (1930) 1930
tumors (1869) 1869
middle aged (1826) 1826
gene expression (1783) 1783
phosphatidylinositol 3-kinases - metabolism (1675) 1675
activation (1628) 1628
genetic aspects (1604) 1604
research (1549) 1549
kinases (1542) 1542
article (1536) 1536
akt (1503) 1503
cell proliferation (1503) 1503
aged (1476) 1476
adult (1440) 1440
analysis (1435) 1435
pten phosphohydrolase (1429) 1429
immunohistochemistry (1382) 1382
pathway (1322) 1322
gene (1260) 1260
gene expression regulation, neoplastic (1258) 1258
growth (1215) 1215
tumor-suppressor (1172) 1172
prognosis (1169) 1169
metastasis (1153) 1153
cells (1086) 1086
phosphatase (1049) 1049
akt protein (1043) 1043
multidisciplinary sciences (1036) 1036
genes (1029) 1029
breast cancer (995) 995
health aspects (955) 955
pathology (951) 951
prostate cancer (947) 947
genetics & heredity (946) 946
carcinoma (937) 937
phosphatases (918) 918
mutations (915) 915
phosphoric monoester hydrolases - genetics (915) 915
signal transduction - drug effects (907) 907
development and progression (880) 880
survival (871) 871
cell cycle (863) 863
research article (860) 860
inhibition (848) 848
proliferation (833) 833
protein (811) 811
micrornas - genetics (810) 810
breast-cancer (808) 808
tumor-suppressor pten (792) 792
medicine (791) 791
medicine, research & experimental (789) 789
cell growth (782) 782
tumor suppressor proteins - genetics (780) 780
physiological aspects (768) 768
phosphatidylinositol 3-kinases - genetics (753) 753
1-phosphatidylinositol 3-kinase (752) 752
care and treatment (746) 746
prostate-cancer (741) 741
apoptosis - drug effects (730) 730
biology (722) 722
mice, knockout (717) 717
down-regulation (711) 711
tumor-suppressor gene (711) 711
microrna (698) 698
rodents (685) 685
blotting, western (679) 679
cells, cultured (678) 678
pi3k (676) 676
transfection (648) 648
disease models, animal (643) 643
signal transduction - physiology (643) 643
progression (640) 640
cell proliferation - drug effects (635) 635
rats (633) 633
tumorigenesis (633) 633
chemotherapy (630) 630
prostatic neoplasms - pathology (628) 628
tumor suppressor genes (626) 626
proto-oncogene proteins c-akt - genetics (625) 625
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14118) 14118
Chinese (272) 272
Japanese (37) 37
French (21) 21
German (13) 13
Russian (11) 11
Korean (6) 6
Spanish (6) 6
Polish (5) 5
Portuguese (4) 4
Turkish (3) 3
Hungarian (2) 2
Bulgarian (1) 1
Czech (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biochemical Journal, ISSN 0264-6021, 12/2007, Volume 408, Issue 3, pp. 297 - 315
The specificities of 65 compounds reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.... 
Drug discovery | Kinase profiling | Protein kinase | Anti-cancer drugs | Inhibitor specificity | RHO-ASSOCIATED KINASE | TUMOR PROGRESSION | FAMILY-MEMBERS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL-PROLIFERATION | protein kinase | P38 MAP KINASE | CYCLIN-DEPENDENT KINASES | RECEPTOR TYROSINE KINASES | drug discovery | kinase profiling | SB 203580 | anti-cancer drugs | ISOFORMS IN-VITRO | P90 RSK | inhibitor specificity | Amino Acid Sequence | Cell Line | Phosphorylation | Recombinant Proteins - antagonists & inhibitors | Animals | Mitogen-Activated Protein Kinases - antagonists & inhibitors | Humans | Drug Design | Protein Kinase Inhibitors - pharmacology | Enzyme Activation | Mitogen-Activated Protein Kinases - metabolism | Spodoptera | Index Medicus | Yes1, Yamaguchi sarcoma viral oncogene homologue 1 | CSK, C-terminal Src kinase | Lck, lymphocyte cell-specific protein-tyrosine kinase | EGF, epidermal growth factor | FGF-R, fibroblast-growth-factor receptor | PAK, p21-activated protein kinase | PDK, 3-phosphoinositide-dependent protein kinase | PI3K, phosphatidylinositol (phosphoinositide) 3-kinase | NEK, NIMA (never in mitosis in Aspergillus nidulans)-related kinase | RSK, p90 ribosomal S6 kinase | HEK-293 cells, human embryonic kidney-293 cells | VEGF, vascular endothelial growth factor (vasoendothelial growth factor) | EF2K, elongation-factor-2 kinase | CK, casein kinase | PTEN, phosphatase and tensin homologue deleted on chromosome 10 | ERK, extracellular-signal-regulated kinase | ATM, ataxia telangiectasia mutated | SRPK, serine-arginine protein kinase | IL-1, interleukin 1 | MNK, MAPK-integrating protein kinase | ROCK, Rho-dependent protein kinase | CaMKK, CaMK kinase | GST, glutathione transferase | MKK1, MAPK kinase-1 (also called MEK1, MAPK or ERK kinase 1) | GAK, cyclin G-associated kinase | FMK, fluoromethylketone | MST, mammalian homologue Ste20-like kinase | PKA, cAMP-dependent protein kinase | FKBP, FK506-binding protein | PPAR, peroxisome-proliferator-activated receptor | IKK, inhibitory κB kinase | PH, pleckstrin homology | MBP, myelin basic protein | AICAR, aminoimidazole-4-carboxamide-1-β-D-ribofuranoside | MAPKAP-K, MAPK-activated protein kinase | Sf21, Spodoptera frugiperda (fall armyworm) 21 | MARK, microtubule-affinity-regulating kinase | PIM, provirus integration site for Moloney murine leukaemia virus | LPS, lipopolysaccharide | MSK, mitogen- and stress-activated protein kinase | MAPK, mitogen-activated protein kinase | MELK, maternal embryonic leucine-zipper kinase | His6, hexahistidine | CAK, cyclin-dependent kinase-activating kinase | Eph-A2, Ephrin A2 receptor | PLK, polo-like kinase | ATF2, activating transcription factor 2 | PKD, protein kinase D | Src, sarcoma kinase | AMPK, AMP-activated protein kinase | MMS, methyl methanesulfonate | CHK, checkpoint kinase | JNK, c-Jun N-terminal kinase | TORC1, mTOR (mammalian target of rapamycin)–raptor (regulatory associated protein of mTOR) complex | BRSK, brain-specific kinase | RIP2, receptor-interacting protein 2 | IGF-1, insulin-like growth factor-1 | S6K1, S6 kinase 1 | DYRK, dual-specificity tyrosine-phosphorylated and -regulated kinase | HIPK, homeodomain-interacting protein kinase | ZMP, aminoimidazole-4-carboxamide-1-β-D-ribofuranoside monophosphate | PRAK, p38-regulated activated kinase | PKC, protein kinase C | Src-I1, Src inhibitor 1 | TANK, TRAF (tumour-necrosis-factor-receptor-associated factor)-family-member-associated nuclear factor κB activator | NFAT, nuclear factor for activated T-cells | PHK, phosphorylase kinase | GSK3, glycogen synthase kinase 3 | PKB, protein kinase B (also called Akt) | CaMK, calmodulin-dependent kinase | CDK, cyclin-dependent protein kinase | NDRG, N-myc downstream-regulated gene | SmMLCK, smooth-muscle myosin light-chain kinase | TBK1, TANK-binding kinase 1 | PRK, protein kinase C-related kinase | SGK, serum- and glucocorticoid-induced kinase
Journal Article
Cancer Cell, ISSN 1535-6108, 2007, Volume 11, Issue 2, pp. 103 - 105
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2013, Volume 31, Issue 34, pp. 4333 - 4342
Purpose The Group for Research in Adult Acute Lymphoblastic Leukemia (GRAALL) recently reported a significantly better outcome in T-cell acute lymphoblastic... 
REGRESSION | ACTIVATION | THERAPY | NOTCH1 | PRETHYMIC PHENOTYPE | ONCOLOGY | PATHWAY | GENES | PTEN | MUTATIONS | EXPRESSION | F-Box-WD Repeat-Containing Protein 7 | Multivariate Analysis | Predictive Value of Tests | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Humans | Male | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Young Adult | Time Factors | DNA Mutational Analysis | Gene Deletion | Cell Cycle Proteins - genetics | Adult | Female | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - therapy | PTEN Phosphohydrolase - genetics | Genetic Predisposition to Disease | Membrane Proteins - genetics | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Disease-Free Survival | Phenotype | GTP Phosphohydrolases - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - classification | Mutation | Receptor, Notch1 - genetics | Ubiquitin-Protein Ligases - genetics | F-Box Proteins - genetics | Index Medicus | GTP Phosphohydrolases | ras Proteins | Innate immunity | Life Sciences | F-Box Proteins | Immunology | PTEN Phosphohydrolase | Proto-Oncogene Proteins | Membrane Proteins | Ubiquitin-Protein Ligases | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Receptor, Notch1 | Cell Cycle Proteins
Journal Article
eLife, ISSN 2050-084X, 2014, Volume 3, pp. e01612 - e01612
Damaged mitochondria can be selectively eliminated by mitophagy. Although two gene products mutated in Parkinson's disease, PINK1, and Parkin have been found... 
Fis1 | rab7 | autophagy | TBC1D15 | Drp1 | Parkin | PARKIN | FIS1 | RECRUITMENT | GTPASE-ACTIVATING PROTEINS | MEMBRANE | PEROXISOMAL FISSION | P62/SQSTM1 | BIOLOGY | DEGRADATION | MAMMALIAN-CELLS | SELECTIVE AUTOPHAGY | Mitochondria - enzymology | Microtubule-Associated Proteins - genetics | Microtubule-Associated Proteins - metabolism | Humans | Protein Multimerization | rab GTP-Binding Proteins - genetics | Mitochondrial Proteins - genetics | GTPase-Activating Proteins - metabolism | Autophagy | Microtubules - metabolism | Ubiquitination | Lysosomes - metabolism | Transfection | Time Factors | Mitochondrial Proteins - metabolism | HEK293 Cells | Lysosomes - pathology | Membrane Proteins - metabolism | Microfilament Proteins - metabolism | Microfilament Proteins - genetics | rab GTP-Binding Proteins - metabolism | Signal Transduction | Membrane Proteins - genetics | HCT116 Cells | Ubiquitin-Protein Ligases - metabolism | Mitochondria - pathology | Mitochondrial Degradation | Autophagy-Related Protein 8 Family | Adaptor Proteins, Signal Transducing - genetics | Protein Binding | GTPase-Activating Proteins - genetics | HeLa Cells | Adaptor Proteins, Signal Transducing - metabolism | Ubiquitin-Protein Ligases - genetics | Membranes | Yeast | Cloning | Glycerol | Mammals | Morphogenesis | Proteins | Mitochondria | GTPase-activating protein | Microscopy | PTEN-induced putative kinase | Morphology | Parkin protein | GABARAP protein | Guanosinetriphosphatase | Index Medicus
Journal Article
Nature Communications, ISSN 2041-1723, 12/2019, Volume 10, Issue 1, pp. 353 - 14
Mucosal melanoma is a rare and poorly characterized subtype of human melanoma. Here we perform a cross-species analysis by sequencing tumor-germline pairs from... 
POINT MUTATIONS | CANCER PATIENTS | BREAST-CANCER | MUTATIONAL PROCESSES | ARRAY-CGH | MULTIDISCIPLINARY SCIENCES | COPY NUMBER | TUMOR | OVARIAN-CANCER | MOUSE MODELS | REVEALS | Proto-Oncogene Proteins c-mdm2 - genetics | Cadherins - metabolism | Humans | Carcinogenesis - metabolism | DNA Copy Number Variations | Germ-Line Mutation | Cadherins - genetics | Neoplasm Proteins - genetics | Mouth Neoplasms - genetics | Protein-Serine-Threonine Kinases - metabolism | PTEN Phosphohydrolase - genetics | Tumor Suppressor Proteins - metabolism | Membrane Proteins - genetics | Carcinogenesis - genetics | Cell Cycle Proteins - metabolism | Melanoma - pathology | Mucous Membrane - pathology | GTP Phosphohydrolases - metabolism | GTP Phosphohydrolases - genetics | Microtubule-Associated Proteins - genetics | Species Specificity | Microtubule-Associated Proteins - metabolism | Gene Expression Regulation, Neoplastic | Mouth Neoplasms - metabolism | Receptor-Like Protein Tyrosine Phosphatases, Class 3 - genetics | Neoplasm Proteins - metabolism | Tumor Suppressor Protein p53 - genetics | Melanoma - genetics | BRCA1 Protein - metabolism | Tumor Suppressor Proteins - genetics | Cell Cycle Proteins - genetics | Membrane Proteins - metabolism | Proto-Oncogene Proteins c-mdm2 - metabolism | Melanoma - metabolism | Skin Neoplasms - pathology | Neoplasm Recurrence, Local | Protein-Serine-Threonine Kinases - genetics | Tumor Suppressor Protein p53 - metabolism | PTEN Phosphohydrolase - metabolism | Mucous Membrane - metabolism | Skin Neoplasms - metabolism | Carcinogenesis - pathology | BRCA1 Protein - genetics | Animals | BRCA2 Protein - metabolism | Receptor-Like Protein Tyrosine Phosphatases, Class 3 - metabolism | Skin Neoplasms - genetics | Dogs | Horses | Mouth Neoplasms - pathology | BRCA2 Protein - genetics | BRCA2 protein | MDM2 protein | BRCA1 protein | Copy number | p53 Protein | Mucosa | Melanoma | Data processing | Breast cancer | Metastases | Heterogeneity | Human performance | Tumorigenesis | Mutation | Species | PTEN protein | Tumors | Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 04/2011, Volume 71, Issue 7, pp. 2750 - 2760
This study addresses the role of PTEN loss in intrinsic resistance to the BRAF inhibitor PLX4720. Immunohistochemical staining of a tissue array covering all... 
METASTATIC MELANOMA | APOPTOSIS | PROTEIN | ONCOLOGY | PHOSPHORYLATION | CUTANEOUS MELANOMA | RAF KINASE | CANCER | MEDIATES RESISTANCE | LINES | ERK | RNA, Small Interfering - genetics | Up-Regulation | Humans | Drug Resistance, Neoplasm | Phosphatidylinositol 3-Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Proto-Oncogene Proteins - biosynthesis | Bcl-2-Like Protein 11 | Melanoma - genetics | Apoptosis Regulatory Proteins - genetics | Indoles - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Proto-Oncogene Proteins B-raf - metabolism | Apoptosis Regulatory Proteins - biosynthesis | Melanoma - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | PTEN Phosphohydrolase - deficiency | Membrane Proteins - genetics | PTEN Phosphohydrolase - biosynthesis | Proto-Oncogene Proteins - genetics | Melanoma - pathology | Sulfonamides - pharmacology | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Membrane Proteins - biosynthesis | Membrane Proteins - antagonists & inhibitors | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Apoptosis Regulatory Proteins - antagonists & inhibitors | Cell Line, Tumor | Protein Kinase Inhibitors - pharmacology | Apoptosis - physiology | Mutation | RNA, Small Interfering - administration & dosage | Index Medicus | PTEN | melanoma | BRAF | PLX4032 | therapy | resistance
Journal Article
Aging Cell, ISSN 1474-9718, 10/2017, Volume 16, Issue 5, pp. 976 - 987
Aging is accompanied with unfavorable geometric and functional changes in the heart involving dysregulation of Akt and autophagy. This study examined the... 
cardiac geometry | contractile function | autophagy | aging | Akt | RAPAMYCIN | PROTEIN-KINASE | DIASTOLIC DYSFUNCTION | CELL BIOLOGY | GERIATRICS & GERONTOLOGY | HYPERTROPHY | LONGEVITY | OVEREXPRESSION | INSULIN-RESISTANCE | CALORIC RESTRICTION | SENESCENCE | MITOCHONDRIAL INJURY | Adaptation, Physiological | Protein Kinases - metabolism | Sirtuin 1 - metabolism | Phosphorylation | Protein Kinases - genetics | Microtubule-Associated Proteins - genetics | Calcium - metabolism | Microtubule-Associated Proteins - metabolism | Autophagy-Related Protein 7 - metabolism | Proto-Oncogene Proteins c-akt - deficiency | Atrial Remodeling - drug effects | Myocardial Contraction - drug effects | Cardiomegaly - pathology | Male | Mitochondrial Proteins - genetics | Sirtuin 1 - genetics | Autophagy - drug effects | Heterocyclic Compounds, 4 or More Rings - pharmacology | Proto-Oncogene Proteins c-akt - genetics | Mitochondrial Proteins - metabolism | Myocardium - metabolism | Membrane Proteins - metabolism | Autophagy - genetics | Forkhead Box Protein O1 - metabolism | Sarcoplasmic Reticulum Calcium-Transporting ATPases - metabolism | Signal Transduction | Membrane Proteins - genetics | Gene Expression Regulation | Myocardium - pathology | Mitochondria - metabolism | Longevity - genetics | Mitochondria - pathology | Autophagy-Related Protein 7 - genetics | Sirolimus - pharmacology | Mice, Knockout | Animals | Cardiomegaly - prevention & control | Beclin-1 - genetics | Mice | Beclin-1 - metabolism | Cardiomegaly - genetics | Sarcoplasmic Reticulum Calcium-Transporting ATPases - genetics | Forkhead Box Protein O1 - genetics | Cardiomegaly - metabolism | Heart | Laws, regulations and rules | Ablation (Surgery) | AKT protein | Autophagy | Ca2+-transporting ATPase | Mitochondria | FOXO1 protein | Aging | Oxidation | Fura-2 | Acetylation | Heart diseases | Calcium (intracellular) | Echocardiography | Contractility | AKT2 protein | Cardiomyocytes | Rapamycin | Insulin | Muscle contraction | BNIP3 protein | Life span | PTEN-induced putative kinase | Parkin protein | Intracellular | PTEN protein | Phagocytosis | Hypertrophy | Index Medicus | Original
Journal Article
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 4795 - 13
Doxorubicin (DOX) is the mainstay chemotherapeutic agent against a variety of human neoplasmas. However, its clinical utility is limited by its marked... 
PROGRAMMED CELL-DEATH | MITOCHONDRIAL APOPTOSIS | OXIDATIVE STRESS | INDUCED CARDIOTOXICITY | INDUCED APOPTOSIS | MULTIDISCIPLINARY SCIENCES | IN-VIVO | HYDROGEN-PEROXIDE | NF-KAPPA-B | UP-REGULATION | BCL-2 FAMILY | Apoptosis - drug effects | Caspase 3 - metabolism | Cardiomyopathies - prevention & control | Male | NF-kappa B - metabolism | Cytochromes c - genetics | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - genetics | Proto-Oncogene Proteins c-akt - genetics | Tumor Suppressor Protein p53 - genetics | Cardiomyopathies - genetics | Proto-Oncogene Proteins c-bcl-2 - metabolism | Caspase 3 - genetics | Apoptosis Regulatory Proteins - genetics | Flavonoids - pharmacology | p38 Mitogen-Activated Protein Kinases - metabolism | Proto-Oncogene Proteins c-akt - metabolism | bcl-2-Associated X Protein - genetics | Cardiotoxicity - prevention & control | Drug Administration Schedule | Signal Transduction | Cytochromes c - metabolism | Tumor Suppressor Protein p53 - metabolism | bcl-2-Associated X Protein - metabolism | Rats | p38 Mitogen-Activated Protein Kinases - genetics | Cardiomyopathies - pathology | Antioxidants - pharmacology | Cardiotonic Agents - pharmacology | Rats, Sprague-Dawley | Doxorubicin - toxicity | Apoptosis Regulatory Proteins - metabolism | Gene Expression Regulation - drug effects | Myocytes, Cardiac - pathology | Animals | Myocytes, Cardiac - drug effects | NF-kappa B - genetics | Myocytes, Cardiac - metabolism | Proto-Oncogene Proteins c-bcl-2 - genetics | Cardiomyopathies - chemically induced | Oxidative stress | NF-κB protein | Conduction | Bax protein | Bcl-2 protein | Cardiomyopathy | p53 Protein | Lipid peroxidation | Caspase | MAP kinase | JNK protein | AKT protein | Inflammation | Caspase-3 | Doxorubicin | Cytochrome c | Antioxidants | Molecular modelling | Rodents | Vascular endothelial growth factor | PTEN protein | Apoptosis | Cancer | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 05/2006, Volume 441, Issue 7092, pp. 523 - 527
The proto-oncogene AKT (also known as PKB) is activated in many human cancers, mostly owing to loss of the PTEN tumour suppressor. In such tumours, AKT becomes... 
FORKHEAD TRANSCRIPTION FACTOR | APOPTOSIS | MULTIDISCIPLINARY SCIENCES | PROSTATE-CANCER | MUTATION | PTEN | MICE | FOXO3A | CELL-SURVIVAL | PML | PHOSPHATASES | Phosphorylation | Phosphoprotein Phosphatases - metabolism | Transcription Factors - deficiency | Neoplasm Proteins - metabolism | Cell Nucleus - enzymology | Tumor Suppressor Proteins - deficiency | Nuclear Proteins - deficiency | Tumor Suppressor Proteins - genetics | Female | Neoplasm Proteins - genetics | Nuclear Proteins - genetics | Proto-Oncogene Proteins c-akt - metabolism | PTEN Phosphohydrolase - genetics | PTEN Phosphohydrolase - deficiency | Tumor Suppressor Proteins - metabolism | Cells, Cultured | Nuclear Proteins - metabolism | Transcription Factors - genetics | Protein Transport | Transcription Factors - metabolism | Animals | Mice | Neoplasm Proteins - deficiency | Promyelocytic Leukemia Protein | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Membranes | Transcription factors | Inhibitor drugs | Pathogenesis | Oncology | AKT protein | Inactivation | Rodents | Cell cycle | Forkhead protein | Tumorigenesis | Null cells | FOXO3 protein | Phenotypes | Deactivation | Medical treatment | Cell membranes | Cell membranes (biology) | Sterility | Mutants | Cyclin-dependent kinase inhibitor p27 | Mutation | Prostate | PTEN protein | Tumors | Cancer | Apoptosis | Index Medicus
Journal Article